Ciba-Geigy
Records under this name other than patents Ciba-Geigy holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,897,918 | Compositions and Methods to Increase Production now held by Seqirus UK Limited In force · Medium confidence | In force | Medium confidence | |
| US 8,088,313 | Process for the Manufacture of Mouldings now held by Novartis AG Term ended Ended no later than Jan 24, 2017 · Low confidence | Term ended | Ended no later than Jan 24, 2017 | Low confidence |
| US 6,939,711 | Control of Gene Expression in Plants by Receptor Mediated Transactivation in the Presence of a Chemical Ligand now held by Syngenta Investment Corporation Term ended Ended no later than Jun 19, 2016 · Low confidence | Term ended | Ended no later than Jun 19, 2016 | Low confidence |
| US 9,612,455 | Extended Wear Ophthalmic Lens now held by Ciba Vision Corporation Term ended Term ended Mar 25, 2016 · Medium confidence | Term ended | Term ended Mar 25, 2016 | Medium confidence |
| US 7,253,257 | Human Metabotropic Glutamate Receptor Subtype MGLUR7B merged into Novartis Corporation Lapsed on the fee record Ended Aug 7, 2015 · Medium confidence | Lapsed on the fee record | Ended Aug 7, 2015 | Medium confidence |
| US 7,468,398 | Extended Wear Ophthalmic Lens now held by Novartis AG Term ended Term ended Jan 29, 2015 · Medium confidence | Term ended | Term ended Jan 29, 2015 | Medium confidence |
| US 7,538,146 | Extended Wear Ophthalmic Lens now held by Novartis AG Term ended Term ended Sep 6, 2014 · Medium confidence | Term ended | Term ended Sep 6, 2014 | Medium confidence |
| US 7,553,880 | Extended Wear Ophthalmic Lens now held by Novartis AG Term ended Term ended Sep 6, 2014 · Medium confidence | Term ended | Term ended Sep 6, 2014 | Medium confidence |
| US 8,415,404 | Extended Wear Ophthalmic Lens now held by Novartis AG Term ended Term ended Sep 6, 2014 · Medium confidence | Term ended | Term ended Sep 6, 2014 | Medium confidence |
| US 8,568,626 | Extended Wear Ophthalmic Lens now held by Novartis AG Term ended Term ended Sep 6, 2014 · Medium confidence | Term ended | Term ended Sep 6, 2014 | Medium confidence |